175 related articles for article (PubMed ID: 8996218)
1. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats.
Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):384-92. PubMed ID: 8996219
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Cosford ND
Brain Res; 2008 Oct; 1234():16-24. PubMed ID: 18692487
[TBL] [Abstract][Full Text] [Related]
4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
Sacaan AI; Dunlop JL; Lloyd GK
J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
[TBL] [Abstract][Full Text] [Related]
6. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine.
Rao TS; Sacaan AI; Menzaghi FM; Reid RT; Adams PB; Correa LD; Whelan KT; Vernier JM
Brain Res; 2004 Apr; 1003(1-2):42-53. PubMed ID: 15019562
[TBL] [Abstract][Full Text] [Related]
8. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
9. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380.
Mogg AJ; Jones FA; Pullar IA; Sharples CG; Wonnacott S
Neuropharmacology; 2004 Nov; 47(6):848-59. PubMed ID: 15527819
[TBL] [Abstract][Full Text] [Related]
10. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
Dwoskin LP; Teng L; Buxton ST; Crooks PA
J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
[TBL] [Abstract][Full Text] [Related]
11. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Suto CM; Vernier JM
Brain Res; 2003 Aug; 981(1-2):85-98. PubMed ID: 12885429
[TBL] [Abstract][Full Text] [Related]
13. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
[TBL] [Abstract][Full Text] [Related]
14. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
[TBL] [Abstract][Full Text] [Related]
15. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
16. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
17. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.
Cao YJ; Surowy CS; Puttfarcken PS
J Pharmacol Exp Ther; 2005 Mar; 312(3):1298-304. PubMed ID: 15542623
[TBL] [Abstract][Full Text] [Related]
19. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
[TBL] [Abstract][Full Text] [Related]
20. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
